Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
2(25%)
Results Posted
100%(5 trials)
Terminated
1(13%)

Phase Distribution

Ph phase_1
1
13%
Ph phase_4
2
25%
Ph phase_2
4
50%

Phase Distribution

1

Early Stage

4

Mid Stage

2

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
1(14.3%)
Phase 2Efficacy & side effects
4(57.1%)
Phase 4Post-market surveillance
2(28.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

2

trials recruiting

Total Trials

8

all time

Status Distribution
Active(2)
Completed(5)
Terminated(1)

Detailed Status

Completed5
Recruiting2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
2
Success Rate
83.3%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (14.3%)
Phase 24 (57.1%)
Phase 42 (28.6%)

Trials by Status

terminated113%
recruiting225%
completed563%

Recent Activity

2 active trials
Showing 5 of 8
recruitingphase_4

Concurrent Versus Sequential Administration of Tdap and RSV Vaccines in Pregnancy

NCT07097012
completedphase_4

Immunogenicity of RSV Vaccines in Residents of Long-Term Care Facilities (LTCF)

NCT06077149
terminatedphase_2

A Study of an Ad26.RSV.preF-based Regimen in the Prevention of Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)-Confirmed Respiratory Syncytial Virus (RSV)-Mediated Lower Respiratory Tract Disease in Adults Aged 65 Years and Older

NCT03982199
completedphase_2

A Study to Evaluate a Range of Dose Levels of an Adenovirus Serotype 26 (Ad26.RSV.preF)-Based Vaccine in Older Adults

NCT04453202
completedphase_1

A Study to Evaluate the Single Vaccination of an Adenovirus Serotype 26 Pre-Fusion F (Ad26.preF) Based Respiratory Syncytial Virus (RSV) Vaccine in Japanese Adults Aged 60 Years and Older

NCT04354480
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT07097012Phase 4

Concurrent Versus Sequential Administration of Tdap and RSV Vaccines in Pregnancy

Recruiting
NCT06077149Phase 4

Immunogenicity of RSV Vaccines in Residents of Long-Term Care Facilities (LTCF)

Completed
NCT03982199Phase 2

A Study of an Ad26.RSV.preF-based Regimen in the Prevention of Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)-Confirmed Respiratory Syncytial Virus (RSV)-Mediated Lower Respiratory Tract Disease in Adults Aged 65 Years and Older

Terminated
NCT04453202Phase 2

A Study to Evaluate a Range of Dose Levels of an Adenovirus Serotype 26 (Ad26.RSV.preF)-Based Vaccine in Older Adults

Completed
NCT04354480Phase 1

A Study to Evaluate the Single Vaccination of an Adenovirus Serotype 26 Pre-Fusion F (Ad26.preF) Based Respiratory Syncytial Virus (RSV) Vaccine in Japanese Adults Aged 60 Years and Older

Completed
NCT06521944

RSV Vaccine Pregnancy Registry

Recruiting
NCT04032093Phase 2

A PHASE 2B PLACEBO-CONTROLLED, RANDOMIZED STUDY OF A RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE IN PREGNANT WOMEN

Completed
NCT04071158Phase 2

A STUDY OF A RSV VACCINE WHEN GIVEN TOGETHER WITH TDAP IN HEALTHY NONPREGNANT WOMEN AGED BETWEEN 18 TO 49 YEARS

Completed

All 8 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
8